Your browser is no longer supported. Please, upgrade your browser.
Settings
PFE [NYSE]
Pfizer Inc.
IndexS&P 500 P/E20.31 EPS (ttm)1.67 Insider Own0.05% Shs Outstand5.56B Perf Week-2.14%
Market Cap188.69B Forward P/E11.05 EPS next Y3.06 Insider Trans-6.42% Shs Float5.55B Perf Month-9.35%
Income9.36B PEG5.64 EPS next Q0.78 Inst Own68.10% Short Float1.14% Perf Quarter-7.39%
Sales47.64B P/S3.96 EPS this Y62.30% Inst Trans- Short Ratio1.51 Perf Half Y-7.09%
Book/sh11.74 P/B2.88 EPS next Y-7.47% ROA8.20% Target Price41.09 Perf Year2.78%
Cash/sh1.88 P/C17.97 EPS next 5Y3.60% ROE22.00% 52W Range26.42 - 43.08 Perf YTD-8.12%
Dividend1.56 P/FCF41.24 EPS past 5Y14.70% ROI14.70% 52W High-21.49% Beta0.65
Dividend %4.61% Quick Ratio1.10 Sales past 5Y0.90% Gross Margin79.10% 52W Low28.00% ATR0.51
Employees88300 Current Ratio1.40 Sales Q/Q-4.30% Oper. Margin32.10% RSI (14)28.68 Volatility1.23% 1.53%
OptionableYes Debt/Eq0.97 EPS Q/Q-71.30% Profit Margin29.70% Rel Volume0.89 Prev Close33.75
ShortableYes LT Debt/Eq0.76 EarningsFeb 02 BMO Payout57.90% Avg Volume41.89M Price33.82
Recom2.60 SMA20-3.04% SMA50-6.97% SMA200-4.56% Volume37,318,286 Change0.21%
Feb-04-21Upgrade DZ Bank Hold → Buy $41
Dec-16-20Downgrade RBC Capital Mkts Outperform → Sector Perform $43 → $42
Nov-19-20Resumed Goldman Neutral $40
Nov-10-20Resumed Bernstein Mkt Perform $42
Oct-12-20Downgrade Atlantic Equities Overweight → Neutral $44 → $39
Sep-29-20Initiated Berenberg Hold $38
Jun-16-20Initiated SVB Leerink Mkt Perform $40
Feb-27-20Upgrade Standpoint Research Hold → Buy
Feb-27-20Initiated Barclays Equal Weight $36
Feb-06-20Initiated Mizuho Buy
Jan-07-20Initiated RBC Capital Mkts Outperform $46
Oct-17-19Resumed BofA/Merrill Neutral $37
Jul-30-19Downgrade Morgan Stanley Overweight → Equal-Weight $48 → $40
Jul-30-19Downgrade BofA/Merrill Buy → Neutral
Jun-04-19Resumed Morgan Stanley Overweight $48
Feb-20-19Resumed Citigroup Neutral $41
Jan-31-19Upgrade Credit Suisse Neutral → Outperform
Jan-31-19Upgrade Argus Hold → Buy
Jan-23-19Downgrade UBS Buy → Neutral
Dec-11-18Downgrade JP Morgan Overweight → Neutral
Feb-25-21 08:17PM  
06:00PM  
05:15PM  
05:00PM  
04:52PM  
04:42PM  
02:42PM  
02:24PM  
12:46PM  
12:40PM  
12:07PM  
10:33AM  
09:00AM  
08:10AM  
08:08AM  
08:03AM  
08:00AM  
07:45AM  
07:39AM  
07:30AM  
07:10AM  
07:08AM  
07:03AM  
07:03AM  
07:00AM  
06:45AM  
06:45AM  
06:00AM  
05:07AM  
02:04AM  
12:13AM  
Feb-24-21 07:01PM  
06:06PM  
05:00PM  
04:42PM  
04:37PM  
04:12PM  
12:03PM  
11:35AM  
10:29AM  
09:31AM  
08:25AM  
08:14AM  
08:03AM  
08:00AM  
06:17AM  
04:08AM  
03:52AM  
03:22AM  
02:46AM  
Feb-23-21 04:30PM  
03:54PM  
03:38PM  
02:08PM  
02:05PM  
11:57AM  
10:55AM  
10:50AM  
09:43AM  
08:56AM  
08:33AM  
08:15AM  
05:51AM  
02:49AM  
02:00AM  
Feb-22-21 11:16PM  
08:06PM  
06:13PM  
04:55PM  
04:36PM  
04:21PM  
02:55PM  
01:01PM  
10:30AM  
10:05AM  
10:00AM  
09:12AM  
09:00AM  
08:49AM  
07:46AM  
07:09AM  
06:07AM  
05:29AM  
05:28AM  
01:52AM  
Feb-21-21 10:28PM  
09:09PM  
07:00PM  
07:00PM  
05:38PM  
04:57PM  
04:27PM  
11:01AM  
09:00AM  
06:09AM  
02:16AM  
Feb-20-21 08:22PM  
08:10PM  
07:00PM  
03:02PM  
Pfizer Inc. develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Sutent, Xtandi, Xalkori, Inlyta, Braftovi + Mektovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Vfend, and Zithromax brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, and tick-borne encephalitis under the Prevnar 13/Prevenar 13 (pediatric/adult), FSME-IMMUN, Nimenrix, and Trumenba brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, Genotropin, and Refacto AF/Xyntha brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company, Astellas Pharma US, Inc., Myovant Sciences Ltd., Akcea Therapeutics, Inc, Verily Life Sciences LLC, Merck KGaA, Valneva SE, IDEAYA Biosciences, Inc., BioNTech SE, Jiangsu Alphamab Biopharmaceuticals Co., Ltd, BioInvent International AB, Sosei Group Corporation, LianBio, and Imcyse S.A. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BOURLA ALBERTChairman & CEONov 09Sale41.94132,5085,557,38678,273Nov 10 05:55 PM
SUSMAN SALLYExecutive Vice PresidentNov 09Sale41.9443,6621,831,184108,096Nov 10 05:55 PM
PFIZER INC10% OwnerOct 27Buy10.001,200,00012,000,00027,349,211Oct 29 05:44 PM
BLAYLOCK RONALD EDirectorAug 06Buy38.5513,000501,08513,000Aug 10 08:07 AM
DAMICO JENNIFER B.SVP & ControllerJun 05Sale36.132,18178,8007,542Jun 08 04:29 PM
Dolsten MikaelPresident R&DMay 18Sale37.7895,3533,602,681174,918May 19 05:37 PM
DAMICO JENNIFER B.SVP & ControllerApr 29Sale38.352,18183,6419,647May 01 03:56 PM
JOHNSON RADY AExecutive Vice PresidentApr 29Sale38.3613,125503,47563,940May 01 03:56 PM
ROGERS DAWNExecutive Vice PresidentApr 29Sale38.1313,000495,6904,823May 01 03:56 PM
LANKLER DOUGLAS MExecutive Vice PresidentApr 29Sale37.8565,0002,460,37278,276May 01 03:56 PM
PFIZER INC10% OwnerMar 16Buy16.00312,5005,000,0001,481,719Mar 16 07:15 PM
GOETTLER MICHAELGroup PresidentFeb 28Option Exercise27.3722,852625,45953,036Mar 03 12:54 PM
JOHNSON RADY AExecutive Vice PresidentFeb 28Option Exercise27.3715,996437,81187,956Mar 03 12:54 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 28Option Exercise27.3738,8481,063,270172,542Mar 03 12:54 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentFeb 28Option Exercise27.3737,9341,038,254140,256Mar 03 12:54 PM
ROGERS DAWNExecutive Vice PresidentFeb 28Option Exercise27.3717,824487,84330,045Mar 03 12:54 PM
SUSMAN SALLYExecutive Vice PresidentFeb 28Option Exercise27.3791,4082,501,837222,496Mar 03 12:55 PM
YOUNG JOHN DGroup PresidentFeb 28Option Exercise27.37100,5482,751,999504,427Mar 03 12:55 PM
BOURLA ALBERTChairman & CEOFeb 28Option Exercise27.3733,135906,905232,888Mar 03 12:49 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 28Option Exercise27.3727,422750,540140,744Mar 03 12:49 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 28Option Exercise27.37173,6754,753,485556,084Mar 03 12:49 PM
YOUNG JOHN DGroup PresidentFeb 26Option Exercise34.59144,9285,013,060503,738Feb 28 07:32 PM
ROGERS DAWNExecutive Vice PresidentFeb 26Option Exercise34.5915,097522,20524,995Feb 28 07:28 PM
SUSMAN SALLYExecutive Vice PresidentFeb 26Option Exercise34.5972,4642,506,530180,558Feb 28 07:28 PM
JOHNSON RADY AExecutive Vice PresidentFeb 26Option Exercise34.5933,4141,155,79093,211Feb 28 07:24 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 26Option Exercise34.5988,5673,063,533189,936Feb 28 07:25 PM
GOETTLER MICHAELGroup PresidentFeb 26Option Exercise34.5920,129696,26245,557Feb 28 07:22 PM
Hwang AngelaGroup PresidentFeb 26Option Exercise34.5914,493501,31332,470Feb 28 07:22 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 26Option Exercise34.59144,9285,013,060482,320Feb 28 07:19 PM
BOURLA ALBERTChairman & CEOFeb 26Option Exercise34.5988,5673,063,533274,479Feb 28 07:16 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 26Option Exercise34.5924,155835,521131,196Feb 28 07:15 PM